Találati lista | Tudóstér

001-es BibID:	BIBFORM060690
Első szerző:	Papp Gábor (belgyógyász)
Cím:	The assessment of immune-regulatory effects of extracorporeal photopheresis in systemic sclerosis : a long-term follow-up study / Gabor Papp, Ildiko Fanny Horvath, Edit Gyimesi, Sandor Barath, Judit Vegh, Peter Szodoray, Margit Zeher
Dátum:	2016
ISSN:	0257-277X
Megjegyzések:	The therapeutic options in systemic sclerosis (SSc) are limited mainly to the management of complications, and decelerating fibrosis and preventing disease progression are still great challenges. Extracorporeal photopheresis (ECP) is one of the promising therapeutic strategies in SSc; nevertheless, there is no consensus on the ideal timing and frequency of treatment cycles. In the present study, we evaluated the long-term effects of consecutive ECP treatments, and the stability of clinical and laboratory improvements. We enrolled nine patients with diffuse cutaneous SSc and performed 12 ECP cycles (24 ECP treatments) per patient in total. ECP cycles were carried out once in every 6 weeks, and each cycle consisted of two procedures. Sixteen healthy individuals served as controls for laboratory assessment. Following the sixth ECP cycle, we observed further improvement in skin score, which was confirmed by high-resolution ultrasonography as well. After the second ECP cycle, values of Tr1 and CD4?CD25bright Treg cells increased; however, Tr1 cells remained under control values until the 10th cycle. Suppressor activity of CD4?CD25? Treg cells improved, while percentages of Th17 cells decreased. At the end of 12-month follow-up, we did not observe significant deterioration in skin involvement; however, improvement in laboratory parameters diminished after 12 months. If the first six ECP cycles are effective, uninterrupted continuation of treatment should be considered, which may lead to the normalization of Tr1 cell values along with further clinical improvement. Our laboratory observations indicate that immunomodulatory effect of ECP treatments lasts for 1 year only.
Tárgyszavak:	Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban Extracorporeal photopheresis Systemic sclerosis Clinical effects Immunological effects Immune regulation
Megjelenés:	Immunologic Research 64 : 2 (2016), p. 404-411. -
További szerzők:	Horváth Ildikó Fanny (1980-) (belgyógyász, allergológus, klinikai immunológus) Gyimesi Edit (1957-) (klinikai biokémikus, vegyész) Baráth Sándor (1977-) (biológus) Végh Judit (1968-) (belgyógyász, kardiológus) Szodoray Péter (1973-) (belgyógyász, orvos) Zeher Margit (1957-2018) (belgyógyász, allergológus és klinikai immunológus, reumatológus)
Pályázati támogatás:	TÁMOP-4.2.4.A/2-11-1-2012-0001 TÁMOP
Internet cím:	DOI Intézményi repozitóriumban (DEA) tárolt változat
Borító:
Saját polcon:

001-es BibID:	BIBFORM044040
Első szerző:	Szekanecz Zoltán (reumatológus, belgyógyász, immunológus)
Cím:	Superior performance of the CCP3.1 test compared to CCP2 and MCV in the rheumatoid factor-negative RA population / Szekanecz Zoltán, Szabó Zoltán, Zeher Margit, Soós Lilla, Dankó Katalin, Horváth Ildikó, Lakos Gabriella
Dátum:	2013
ISSN:	0257-277X
Megjegyzések:	Anti-citrullinated protein/peptide antibodies (ACPAs) have recently been identified as sensitive and specific diagnostic and prognostic markers in rheumatoid arthritis (RA). In this study, we wished to assess the diagnostic performance of the third-generation anti-CCP3.1 assay, but with special focus on the rheumatoid factor (RF)-negative RA population. Anti-CCP as well as anti-MCV was tested in 119 RA patients and 118 control patients using second and third-generation assays. Using these optimal cut-off levels, the diagnostic sensitivity of anti-CCP2, CCP3, and CCP3.1 was 74.8, 78.8, and 83.0 %, respectively, while the specificity was 95.7, 96.6, and 98.3 %, respectively. The diagnostic performance of the CCP3.1 test was significantly better than that of CCP2 (p = 0.041). In addition, the CCP3.1 test performed significantly better than the MCV test as well (p = 0.0003). When the diagnostic performance of the CCP3.1, CCP2, and MCV tests was compared in the 35 RF-negative patients, the CCP3.1 test exerted significantly better performance than the MCV test (p = 0.006), and it also showed a tendency of better performance in comparison with the CCP2 test (p = 0.131). In conclusion, the CCP3.1 assay can significantly increase the sensitivity of ACPA testing in RF-negative RA, as well as in the total RA population.
Tárgyszavak:	Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban Rheumatoid arthritis Murine arthritis Genetics Single nucleotide polymorphisms HLA-DR GWAS
Megjelenés:	Immunologic Research. - 56 : 2-3 (2013), p. 439-443. -
További szerzők:	Szabó Zoltán (1970-) (belgyógyász, reumatológus) Zeher Margit (1957-2018) (belgyógyász, allergológus és klinikai immunológus, reumatológus) Soós Lilla Dankó Katalin (1952-2021) (belgyógyász, allergológus és klinikai immunológus) Horváth Ildikó Fanny (1980-) (belgyógyász, allergológus, klinikai immunológus) Lakos Gabriella (1963-) (laboratóriumi szakorvos, transzfúziológus, immunológus)
Pályázati támogatás:	TÁMOP-4.2.2.A-11/1/KONV-2012-0031 TÁMOP TÁMOP-4.2.1/B-09/1/KONV-2010-0007 TÁMOP Akcelerált atherosclerosis és cardiovascularis betegségek gyulladásos reumatológiai kórképekben
Internet cím:	Szerző által megadott URL DOI Intézményi repozitóriumban (DEA) tárolt változat
Borító:
Saját polcon: